Avalo Therapeutics to Attend Two Investor Conferences
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Avalo Therapeutics (AVTX) management is scheduled to participate in two investor conferences. They will present at the Guggenheim Healthcare Innovation Conference on November 9, 2026, and the Stifel 2026 Healthcare Conference on November 10, 2026. Webcasts of these fireside chats will be available on the company's investor website for at least 30 days.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.